Paper986308
Methylphenidate-like effects of the new antidepressant drug nomifensine (HOE 984).
Braestrup C and 1 other. Eur J Pharmacol, 1976. Cited by 123 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Methylphenidate-like effects of the new antidepressant drug nomifensine (HOE 984). Papers, record 986308. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/986308
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antidepressive Agents | Major topic |
| Isoquinolines | Major topic |
| Methylphenidate | Major topic |
| Animals | |
| Apomorphine | |
| Benztropine | |
| Cocaine | |
| Corpus Striatum | |
| Dextroamphetamine | |
| Dopamine | |
| Humans | |
| Male | |
| Rats | |
| Reserpine | |
| Stereotyped Behavior | |
| Synaptosomes | |
| Time Factors |
Source PubMed
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 123 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7,889,297 | Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain. | Br J Pharmacol | 1994 | https://conductscience.org/library/papers/7889297 | PubMed |
| 7,241,163 | Nomifensine: effect in Parkinsonian patients not receiving levodopa. | J Neurol Neurosurg Psychiatry | 1981 | https://conductscience.org/library/papers/7241163 | PubMed |
| 6,725,869 | Multicentric experience on the acute effect of nomifensine in hyperprolactinemic women. | J Endocrinol Invest | 1984 | https://conductscience.org/library/papers/6725869 | PubMed |
| 6,408,155 | Nomifensine decreases the thyroid-stimulating-hormone response to thyrotropin-releasing-hormone in normal subjects. | J Endocrinol Invest | 1983 | https://conductscience.org/library/papers/6408155 | PubMed |
| 6,254,586 | Involvement of a central alpha-adrenoceptor system in antidepressant potentiation of hyperthermia induced by thyrotropin releasing hormone. | Br J Pharmacol | 1980 | https://conductscience.org/library/papers/6254586 | PubMed |
| 6,133,737 | Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications. | Drugs | 1983 | https://conductscience.org/library/papers/6133737 | PubMed |
| 3,921,593 | Failure of nomifensine to reduce serum prolactin levels in patients with hepatic encephalopathy. | J Endocrinol Invest | 1985 | https://conductscience.org/library/papers/3921593 | PubMed |
| 3,561,528 | Effects of acute and chronic treatment with an atypical antidepressant drug, nomifensine, on the sleep-wake activity in rats. | Naunyn Schmiedebergs Arch Pharmacol | 1987 | https://conductscience.org/library/papers/3561528 | PubMed |
| 3,401,637 | 4-Hydroxy-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline (PI-OH): a new potentiator of sympathomimetic amines on the rat anococcygeus muscle. | Br J Pharmacol | 1988 | https://conductscience.org/library/papers/3401637 | PubMed |
| 3,100,965 | Dopamine-like activities of an aminopyridazine derivative, CM 30366: a behavioural study. | Naunyn Schmiedebergs Arch Pharmacol | 1986 | https://conductscience.org/library/papers/3100965 | PubMed |
| 2,880,302 | (+)-AJ 76 and (+)-UH 232: central stimulants acting as preferential dopamine autoreceptor antagonists. | Naunyn Schmiedebergs Arch Pharmacol | 1986 | https://conductscience.org/library/papers/2880302 | PubMed |
| 2,693,054 | Rapid eye movement sleep and sleep continuity. Depression and antidepressants. | Drugs | 1989 | https://conductscience.org/library/papers/2693054 | PubMed |
| 2,541,855 | Potentiation by TRH of the effect of antidepressants in the forced-swimming test, involvement of dopaminergic and opioid systems. | Br J Pharmacol | 1989 | https://conductscience.org/library/papers/2541855 | PubMed |
| 2,409,454 | Pharmacology in vivo of the phenylindan derivative, Lu 19-005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brain. | Naunyn Schmiedebergs Arch Pharmacol | 1985 | https://conductscience.org/library/papers/2409454 | PubMed |
| 874,472 | Effect of nomifensine on central 5-hydroxytryptamine neurons. | J Neural Transm | 1977 | https://conductscience.org/library/papers/874472 | PubMed |
| 477,572 | Nomifensine: A review of its pharmacological properties and therapeutic efficacy in depressive illness. | Drugs | 1979 | https://conductscience.org/library/papers/477572 | PubMed |
| 438,800 | Effect of mazindol on brain dopamine turnover in spiperone-treated rats. | J Neural Transm | 1979 | https://conductscience.org/library/papers/438800 | PubMed |
| 408,861 | Uptake inhibition of biogenic amines by newer antidepressant drugs: relevance to the dopamine hypothesis of depression. | Psychopharmacology (Berl) | 1977 | https://conductscience.org/library/papers/408861 | PubMed |
| 334,231 | Review of the pharmacology of existing antidepressants. | Br J Clin Pharmacol | 1977 | https://conductscience.org/library/papers/334231 | PubMed |
| 334,223 | Nomifensine in Parkinson's disease. | Br J Clin Pharmacol | 1977 | https://conductscience.org/library/papers/334223 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/986308
GET https://conductscience.org/api/papers/v1/986308/cited_by?page=2